World Digital Pathology Systems Industry

  • January 2015
  • -
  • Global Industry Analysts
  • -
  • 175 pages

This report analyzes the worldwide markets for Digital Pathology Systems in US$ Thousands. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 50 companies including many key and niche players such as -

3DHISTECH Ltd.
AccelPath, Inc.
Apollo PACS, Inc.
Carl Zeiss AG
Corista LLC

Table Of Contents




I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-2
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
A Prelude II-1
Impact of Economic Recession in Retrospect and the Road Ahead II-2
Market Outlook II-3
Developed Markets to Maintain their Dominance II-3
Digital Pathology Systems See Fast Paced Growth in Emerging
Nations II-4
Analytics: A Fast Growing Segment II-4
Key Issues Hampering the Wider Adoption of Digital Pathology
Systems II-4
The Future in Retrospect II-5

2. MARKET DRIVERS, TRENDS and ISSUES II-6
The Need for Automation in Tissue Analysis II-6
Workflow Efficiencies: A Key Market Driver for Digital
Pathology Systems II-6
Scarcity of Pathologists and Excess Workload on Pathology Labs
Drives Demand for Digital Systems II-7
Need for Early Diagnosis Puts Focus on Digital Pathology II-7
Clinical Research Continues to be Core Vertical for Digital
Pathology II-7
Technological Advances Ease Issues in Digital Pathology Adoption II-8
Possibilities Ahead in Digital Pathology II-9
Digital Pathology Systems Continue to Widen their Scope II-9
Digital Pathology Systems See Fast Paced Adoption in Cancer
and Other Chronic Diseases II-10
Move towards Hosted Technology: The New Fad II-10
Digital Pathology as a Service Eludes Cost-based Issues II-11
Telepathology Expected to Pave Way for Pathology Outsourcing
to Developing Nations II-11
Rising Emphasis on Lab Automation Extends Opportunity for
Digital Pathology II-11
Rising Penetration of Personalized Medicine Bodes Well for
Digital Pathology II-12
Increased Focus on Companion Diagnostics to Benefit the Market II-13
Improving Healthcare and Research Expenditures Turbo Charge
Digital Pathology II-13
Table 1: Per-Capita Healthcare Expenditure in Select Regions
(2013) (includes corresponding Graph/Chart) II-14

Table 2: Top 20 Countries with the Highest Healthcare
Spending as a Percentage of GDP (2012) (includes
corresponding Graph/Chart) II-15
Burgeoning Global Population: A Strong Business Case for
Market Growth II-15
Table 3: Top 25 Countries Worldwide in Terms of Population:
2007, 2010 and 2013 (includes corresponding Graph/Chart) II-16
Aging Population: A Key Opportunity Indicator II-17
Table 4: Global Population Statistics for the 65+ Age Group
(2013) (includes corresponding Graph/Chart) II-18

Table 5: Elderly Population (60+ Years) as a Percentage of
the Total Population (2012 and 2050) (includes corresponding
Graph/Chart) II-19

Table 6: Global Aging Population by Age Group: 1975-2050
(includes corresponding Graph/Chart) II-19
Table 7: Aging Population by Age Group in More Developed
Countries (1975-2050) (includes corresponding Graph/Chart) II-20
Table 8: Aging Population by Age Group in Less Developed
Countries (1975-2050) (includes corresponding Graph/Chart) II-20
Table 9: Aging Population by Age Group in Least Developed
Countries (1975-2050) (includes corresponding Graph/Chart) II-21
Table 10: Life Expectancy at Age 60 and 80 Years -
(2010-2015), (2020-2025) and (2045-2050) (includes
corresponding Graph/Chart) II-21
Key Issues Hampering the Wider Adoption of Digital Pathology
Systems II-22
High Costs II-22
Workflow Integration with Other Related Functions II-22
Other Issues II-22

3. COMPETITION II-23
Leica Dominates the Market II-23
Table 11: Leading Players in the Global Digital Pathology
Systems Market (2013): Percentage Breakdown of Dollar Sales
for Leica, Olympus, Roche/Ventana and Others (includes
corresponding Graph/Chart) II-23
Consolidation Rife in the Digital Pathology Space II-23

4. PRODUCT OVERVIEW II-24
An Introduction to Pathology II-24
Digital Pathology: Computer-Enabled Pathology Process II-24
Digital Pathology System: Components II-24
Slide Scanners II-25
Analytics II-25
Storage II-25
Communication II-25
Applications II-25
Remote Reviewing II-25
Digital-Assisted Mathematical Analysis II-26
Data Storage II-26
Telepathology II-26
Static Telepathology II-26
Dynamic Telepathology II-26
Hybrid Telepathology II-27
Bio-banking II-27
Multinational Integration II-27
Tissue Microarray Analysis II-27
A Review of Information Archival and Retrieval in Digital
Pathology II-27
Storage and Interoperability II-28
Location and Internal Communication II-28
Systems and Data Reliability II-28
Image Life-Cycle Management II-29
IT infrastructure and Management Costs II-29
Factors Affecting Information Archival II-29
Digital Pathology Management Systems II-29
Benefits of Digital Pathology Systems II-30
Easier Analysis and Archival and Retrieval of Digital Images II-30
Access to Digital Slide Images Anytime Anywhere II-31

5. PRODUCT INTRODUCTIONS/INNOVATIONS II-32
Philips Obtains CE Mark Approval for Diagnostic Use of its
Philips Digital Pathology Solution II-32
Mikroscan Technologies Unveils Mikroscan L6 and the Mikroscan
MC2 Telepathology Systems II-32
Royal Philips Receives FDA 510(k) Clearance for Her2/neu IHC
Digital Manual Read Product II-32
Ventana Medical Systems Launches iScan HT Slide Scanner II-32
Ventana Obtains FDA 510(k) Clearance for VENTANA Companion
Algorithm Ki-67 (30-9) Image Analysis Solution II-32

6. RECENT INDUSTRY ACTIVITY II-33
Visiopharm Begins Operations in Benelux II-33
Pixcelldata Selects Edge Solutions as its US Partner II-33
CellNetix Pathology and Laboratories Merges with Highline
Pathology Associates II-33
Definiens Teams Up with Clarient Diagnostic Services II-33
Pixcelldata Signs Partnership Deal with eX-Path II-33
Pixcelldata Inks Partnership Agreement with Basys Data II-33
IDEXX Laboratories Inks Collaboration Agreement with Royal
Philips II-33
Ventana Medical Systems and EMC Join Hands II-34
XIFIN Acquires PathCentral II-34
Kanteron Systems Signs Joint Selling and Marketing Agreement
with DigiPath II-34
DigiPath Inks New Agreement with Personalized Diagnostic II-34
Dako to Launch Clinical Image Analysis for Digital Pathology II-34
Ventana Medical Systems Inks Global Agreement with Barco II-34
MEDITE Teams Up with UNIC Technologies II-35
Leica Biosystems Takes Over Aperio Technologies II-35
Carl Zeiss MicroImaging and Olympus America Sign Licensing
Agreement II-35
Aperio Technologies and Dell Enter into Strategic Collaboration II-35
AccelPath Acquires DigiPath Solutions II-35
Leica Microsystems and Indica Labs Sign Agreement II-35
Omnyxâ„¢ Receives CE Mark in Europe II-36
Erasmus MC Selects Philips to Adopt Digital Pathology System II-36

7. FOCUS ON SELECT GLOBAL PLAYERS II-37
3DHISTECH Ltd. (Hungary) II-37
AccelPath, Inc. (US) II-37
Apollo PACS, Inc. (US) II-38
Carl Zeiss AG (Germany) II-38
Corista LLC (US) II-39
Definiens AG (Germany) II-39
DigiPath Inc. (US) II-39
Flagship Biosciences, LLC (US) II-40
Koninklijke Philips Electronics N.V. (Netherlands) II-40
Leica Microsystems GmbH (Germany) II-41
MikroScan Technologies, Inc. (US) II-41
Olympus America, Inc. (US) II-42
Omnyx, LLC (US) II-42
Pixcelldata Ltd. (Ireland) II-43
Ventana Medical Systems, Inc. (US) II-43
VMscope GmbH (Germany) II-44

8. GLOBAL MARKET PERSPECTIVE II-45
Table 12: World Recent Past, Current and Future Analysis for
Digital Pathology Systems by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Latin America
and Rest of World Markets Independently Analyzed with Annual
Revenues in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-45

Table 13: World Historic Review for Digital Pathology Systems
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Revenues in US$ Thousand
for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-46

Table 14: World 15-Year Perspective for Digital Pathology
Systems by Geographic Region - Percentage Breakdown of
Revenues for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) II-47


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Market Overview III-1
Increasing Pressure on Pathological Labs - An Opportunity in
Disguise III-1
Regulatory Scenario in the US III-2
Health Insurance Portability and Accountability Act (HIPAA) III-2
Food and Drug Administration (FDA) III-2
Clinical Laboratory Improvement Amendments (CLIA) III-2
Approval Status III-3
Product Launches III-3
Strategic Corporate Developments III-4
Key Players III-6
B.Market Analytics III-10
Table 15: US Recent Past, Current and Future Analysis for
Digital Pathology Systems Market Analyzed with Annual
Revenues in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-10

Table 16: US Historic Review for Digital Pathology Systems
Market Analyzed with Annual Revenues in US$ Thousand for
Years 2006 through 2012 (includes corresponding Graph/Chart) III-11

2. CANADA III-12
A.Market Analysis III-12
Current and Future Analysis III-12
Need for Digital Pathology in Canada III-12
B.Market Analytics III-13
Table 17: Canadian Recent Past, Current and Future Analysis
for Digital Pathology Systems Market Analyzed with Annual
Revenues in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-13

Table 18: Canadian Historic Review for Digital Pathology
Systems Market Analyzed with Annual Revenues in US$ Thousand
for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-14

3. JAPAN III-15
A.Market Analysis III-15
Current and Future Analysis III-15
Digital Pathology in Japan - An Overview III-15
B.Market Analytics III-16
Table 19: Japanese Recent Past, Current and Future Analysis
for Digital Pathology Systems Market Analyzed with Annual
Revenues in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-16

Table 20: Japanese Historic Review for Digital Pathology
Systems Market Analyzed with Annual Revenues in US$ Thousand
for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-17

4. EUROPE III-18
A.Market Analysis III-18
Current and Future Analysis III-18
Strategic Corporate Development III-18
B.Market Analytics III-19
Table 21: European Recent Past, Current and Future Analysis
for Digital Pathology Systems by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets
Independently Analyzed with Annual Revenues in US$ Thousand
for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-19

Table 22: European Historic Review for Digital Pathology
Systems by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets Independently
Analyzed with Annual Revenues in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) III-20

Table 23: European 15-Year Perspective for Digital Pathology
Systems by Geographic Region - Percentage Breakdown of
Revenues for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-21

4a. FRANCE III-22
Market Analysis III-22
Table 24: French Recent Past, Current and Future Analysis
for Digital Pathology Systems Market Analyzed with Annual
Revenues in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-22

Table 25: French Historic Review for Digital Pathology
Systems Market Analyzed with Annual Revenues in US$ Thousand
for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-23

4b. GERMANY III-24
A.Market Analysis III-24
Current and Future Analysis III-24
Strategic Corporate Developments III-24
Select Players III-24
B.Market Analytics III-27
Table 26: German Recent Past, Current and Future Analysis
for Digital Pathology Systems Market Analyzed with Annual
Revenues in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-27

Table 27: German Historic Review for Digital Pathology
Systems Market Analyzed with Annual Revenues in US$ Thousand
for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-28

4c. ITALY III-29
Market Analysis III-29
Table 28: Italian Recent Past, Current and Future Analysis
for Digital Pathology Systems Market Analyzed with Annual
Revenues in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-29

Table 29: Italian Historic Review for Digital Pathology
Systems Market Analyzed with Annual Revenues in US$ Thousand
for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-30

4d. THE UNITED KINGDOM III-31
A.Market Analysis III-31
Current and Future Analysis III-31
Strategic Corporate Development III-31
B.Market Analytics III-31
Table 30: UK Recent Past, Current and Future Analysis for
Digital Pathology Systems Market Analyzed with Annual
Revenues in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-31

Table 31: UK Historic Review for Digital Pathology Systems
Market Analyzed with Annual Revenues in US$ Thousand for
Years 2006 through 2012 (includes corresponding Graph/Chart) III-32

4e. SPAIN III-33
Market Analysis III-33
Table 32: Spanish Recent Past, Current and Future Analysis
for Digital Pathology Systems Market Analyzed with Annual
Revenues in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-33

Table 33: Spanish Historic Review for Digital Pathology
Systems Market Analyzed with Annual Revenues in US$ Thousand
for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-34

4f. RUSSIA III-35
Market Analysis III-35
Table 34: Russian Recent Past, Current and Future Analysis
for Digital Pathology Systems Market Analyzed with Annual
Revenues in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-35

Table 35: Russian Historic Review for Digital Pathology
Systems Market Analyzed with Annual Revenues in US$ Thousand
for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-36

4g. REST OF EUROPE III-37
A.Market Analysis III-37
Current and Future Analysis III-37
Strategic Corporate Developments III-37
Select Players III-38
B.Market Analytics III-40
Table 36: Rest of Europe Recent Past, Current and Future
Analysis for Digital Pathology Systems Market Analyzed with
Annual Revenues in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-40

Table 37: Rest of Europe Historic Review for Digital
Pathology Systems Market Analyzed with Annual Revenues in
US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-41

5. ASIA-PACIFIC III-42
A.Market Analysis III-42
Current and Future Analysis III-42
Asia-Pacific: Gradually Embracing Telepathology III-42
Market Exhibits Faster Growth III-43
South Korea: Limited Adoption despite Adequate Networking
Infrastructure III-43
China: Static Telepathology Remains Popular III-43
Inadequate Infrastructure Impedes Adoption of Digital
Pathology in India III-44
Strategic Corporate Development III-45
B.Market Analytics III-45
Table 38: Asia-Pacific Recent Past, Current and Future
Analysis for Digital Pathology Systems Market Analyzed with
Annual Revenues in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-45

Table 39: Asia-Pacific Historic Review for Digital Pathology
Systems Market Analyzed with Annual Revenues in US$ Thousand
for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-46

6. LATIN AMERICA III-47
Market Analysis III-47
Table 40: Latin American Recent Past, Current and Future
Analysis for Digital Pathology Systems Market Analyzed with
Annual Revenues in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-47

Table 41: Latin American Historic Review for Digital
Pathology Systems Market Analyzed with Annual Revenues in
US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-48

7. REST OF WORLD III-49
A.Market Analysis III-49
Current and Future Analysis III-49
Africa: Digital Pathology finds Few Takers III-49
B.Market Analytics III-50
Table 42: Rest of World Recent Past, Current and Future
Analysis for Digital Pathology Systems Market Analyzed with
Annual Revenues in US$ Thousand for Years 2013 through 2020
(includes corresponding Graph/Chart) III-50

Table 43: Rest of World Historic Review for Digital
Pathology Systems Market Analyzed with Annual Revenues in
US$ Thousand for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-51


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 50 (including Divisions/Subsidiaries - 54)

The United States (27)
Canada (4)
Japan (2)
Europe (19)
- Germany (6)
- The United Kingdom (1)
- Spain (1)
- Rest of Europe (11)
Asia-Pacific (Excluding Japan) (2)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • November 2014
  • by GBI Research

Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The prostate cancer pipeline is among the largest in the ...

Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • November 2014
  • by GBI Research

Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation Summary Large Degree of Innovation in Parkinson's Disease Pipeline The Parkinson's disease (PD) pipeline ...

Biological Therapies for Cancer: Technologies and Global Markets

Biological Therapies for Cancer: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for biologic cancer treatment totaled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.